These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34405855)

  • 1. Decoding the consecutive lysosomal degradation of 3-O-sulfate containing heparan sulfate by Arylsulfatase G (ARSG).
    Kowalewski B; Lange H; Galle S; Dierks T; Lübke T; Damme M
    Biochem J; 2021 Sep; 478(17):3221-3237. PubMed ID: 34405855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice.
    Kowalewski B; Lamanna WC; Lawrence R; Damme M; Stroobants S; Padva M; Kalus I; Frese MA; Lübke T; Lüllmann-Rauch R; D'Hooge R; Esko JD; Dierks T
    Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10310-5. PubMed ID: 22689975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of arylsulfatase G: expression, processing, glycosylation, transport, and activity.
    Kowalewski B; Lübke T; Kollmann K; Braulke T; Reinheckel T; Dierks T; Damme M
    J Biol Chem; 2014 Oct; 289(40):27992-8005. PubMed ID: 25135642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arylsulfatase K inactivation causes mucopolysaccharidosis due to deficient glucuronate desulfation of heparan and chondroitin sulfate.
    Trabszo C; Ramms B; Chopra P; Lüllmann-Rauch R; Stroobants S; Sproß J; Jeschke A; Schinke T; Boons GJ; Esko JD; Lübke T; Dierks T
    Biochem J; 2020 Sep; 477(17):3433-3451. PubMed ID: 32856704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylsulfatase K is the Lysosomal 2-Sulfoglucuronate Sulfatase.
    Dhamale OP; Lawrence R; Wiegmann EM; Shah BA; Al-Mafraji K; Lamanna WC; Lübke T; Dierks T; Boons GJ; Esko JD
    ACS Chem Biol; 2017 Feb; 12(2):367-373. PubMed ID: 28055182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids.
    Bai X; Bame KJ; Habuchi H; Kimata K; Esko JD
    J Biol Chem; 1997 Sep; 272(37):23172-9. PubMed ID: 9287321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of novel sequences containing 3-O-sulfated glucosamine in glomerular basement membrane heparan sulfate and localization of sulfated disaccharides to a peripheral domain.
    Edge AS; Spiro RG
    J Biol Chem; 1990 Sep; 265(26):15874-81. PubMed ID: 2144291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative method to detect non-antithrombin-binding 3-O-sulfated units in heparan sulfate.
    Mochizuki H; Futatsumori H; Suzuki E; Kimata K
    J Biol Chem; 2021; 296():100115. PubMed ID: 33234593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase.
    Bame KJ; Esko JD
    J Biol Chem; 1989 May; 264(14):8059-65. PubMed ID: 2524478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the 3-O-Sulfate Proteome--Enhanced Binding of Neuropilin-1 to 3-O-Sulfated Heparan Sulfate Modulates Its Activity.
    Thacker BE; Seamen E; Lawrence R; Parker MW; Xu Y; Liu J; Vander Kooi CW; Esko JD
    ACS Chem Biol; 2016 Apr; 11(4):971-80. PubMed ID: 26731579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylsulfatase G, a novel lysosomal sulfatase.
    Frese MA; Schulz S; Dierks T
    J Biol Chem; 2008 Apr; 283(17):11388-95. PubMed ID: 18283100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligosaccharide library-based assessment of heparan sulfate 6-O-sulfotransferase substrate specificity.
    Jemth P; Smeds E; Do AT; Habuchi H; Kimata K; Lindahl U; Kusche-Gullberg M
    J Biol Chem; 2003 Jul; 278(27):24371-6. PubMed ID: 12702732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging chemical and biochemical tools for studying 3-
    Liu J; Pedersen LC
    Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1166-C1175. PubMed ID: 35417268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucosamine-6-sulfamate analogues of heparan sulfate as inhibitors of endosulfatases.
    Schelwies M; Brinson D; Otsuki S; Hong YH; Lotz MK; Wong CH; Hanson SR
    Chembiochem; 2010 Nov; 11(17):2393-7. PubMed ID: 20973023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a heparan sulfate 3-O-sulfation specific peeling reaction.
    Huang Y; Mao Y; Zong C; Lin C; Boons GJ; Zaia J
    Anal Chem; 2015 Jan; 87(1):592-600. PubMed ID: 25486437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5.
    Chen J; Duncan MB; Carrick K; Pope RM; Liu J
    Glycobiology; 2003 Nov; 13(11):785-94. PubMed ID: 12907690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal sulfatases: a growing family.
    Lübke T; Damme M
    Biochem J; 2020 Oct; 477(20):3963-3983. PubMed ID: 33120425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of unsulfated heparan chains on the heparan sulfate proteoglycan of human colon carcinoma cells. Implications for heparan sulfate proteoglycan biosynthesis.
    Iozzo RV
    J Biol Chem; 1989 Feb; 264(5):2690-9. PubMed ID: 2521630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New clinical and molecular evidence linking mutations in ARSG to Usher syndrome type IV.
    Peter VG; Quinodoz M; Sadio S; Held S; Rodrigues M; Soares M; Sousa AB; Coutinho Santos L; Damme M; Rivolta C
    Hum Mutat; 2021 Mar; 42(3):261-271. PubMed ID: 33300174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentially expressed patterns of glycosaminoglycan structure in heparan sulfate proteoglycans and free chains.
    Hovingh P; Piepkorn M; Linker A
    Eur J Biochem; 1993 Feb; 211(3):771-9. PubMed ID: 8436134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.